Search Results - "Camargo, Veridiana"

Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial by Schöffski, Patrick, Prof, Chawla, Sant, MD, Maki, Robert G, Prof, Italiano, Antoine, MD, Gelderblom, Hans, Prof, Choy, Edwin, MD, Grignani, Giovanni, MD, Camargo, Veridiana, MD, Bauer, Sebastian, MD, Rha, Sun Young, MD, Blay, Jean-Yves, Prof, Hohenberger, Peter, MD, D'Adamo, David, MD, Guo, Matthew, PhD, Chmielowski, Bartosz, MD, Le Cesne, Axel, MD, Demetri, George D, Prof, Patel, Shreyaskumar R, Prof

“…Summary Background A non-randomised, phase 2 study showed activity and tolerability of eribulin in advanced or metastatic soft-tissue sarcoma. In this phase 3…”
Get full text

A phase 2 study of first‐line nivolumab in patients with locally advanced or metastatic cutaneous squamous‐cell carcinoma by Munhoz, Rodrigo R., Nader‐Marta, Guilherme, Camargo, Veridiana P., Queiroz, Marcello M., Cury‐Martins, Jade, Ricci, Hermínia, Mattos, Marcela R., Menezes, Thiago A. F., Machado, Guilherme U. C., Bertolli, Eduardo, Barros, Milton, Souza, Carina E., Franke, Fábio, Ferreira, Fabio O., Feher, Olavo, Castro, Gilberto

“…Background Cutaneous squamous‐cell carcinoma (CSCC) is among the most frequent malignancies worldwide. For those not amenable to treatment with curative…”
Get full text

Neoadjuvant stereotactic ablative radiotherapy (SABR) for soft tissue sarcomas of the extremities by Leite, Elton Trigo Teixeira, Munhoz, Rodrigo Ramella, Camargo, Veridiana Pires de, Lima, Luiz Guilherme Cernaglia Aureliano de, Rebolledo, Daniel Cesar Seguel, Maistro, Carlos Eduardo Bravin, Busnardo, Fábio de Freitas, Ferreira, Fábio de Oliveira, Salvajoli, João Victor, Carvalho, Heloisa de Andrade

“…•Radiotherapy improves local control rates for soft tissue sarcoma of extremities.•There is a global trend to shorten radiation schemes.•Ablative radiotherapy…”
Get full text

Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor) by de Camargo, Veridiana Pires, Keohan, Mary L., D'Adamo, David R., Antonescu, Cristina R., Brennan, Murray F., Singer, Samuel, Ahn, Linda S., Maki, Robert G.

“…BACKGROUND: In the current study, the authors examined the outcomes of patients with desmoid tumors who received systemic therapy at a single institution to…”
Get full text

BRAF-Mutated Melanoma Journey in Latin America: Expert Recommendations From Diagnosis to Treatment by Bravo-Garzón, María A, Bornstein-Quevedo, Leticia, Camargo, Veridiana Pires de, Sanku, Gayatri, Jansen, Angela Marie, Macedo, Mariana Petaccia de, Rico-Restrepo, Mariana, Chacón, Matías

“…• Gather a panel of Latin American experts in testing and treating -melanoma. • Describe the current landscape of -mutated melanoma in Latin America. • Outline…”
Get full text

Brazilian consensus on the diagnosis and treatment of extremities soft tissue sarcomas by Spencer, Ranyell M. S. S. B., Camargo, Veridiana P., Silva, Maria L. G., Pinto, Fabio F. E., Costa, Felipe D'Almeida, Cequeira, Wagner S., Munhoz, Rodrigo R., Mello, Celso A., Schmerling, Rafael A., Filho, Waldec J. D., Coelho, Tharcisio M., Ambrosio, Alexandre V. A., Leite, Elton T. T., Hanna, Samir A., Nakagawa, Sueli A., Baptista, Andre M., Pinheiro, Rodrigo N., Oliveira, Jadivan L., Araújo, Marcelo Sá, Araujo, Raphael L. C., Laporte, Gustavo A., Almeida Quadros, Claudio, Oliveira, Alexandre F., Lopes, Ademar

“…Introduction Soft tissue sarcomas (STSs) are rare tumors and constitute only 1% of all tumors in adults. Indeed, due to their rarity, most cases in Brazil are…”
Get full text

Approaching glioblastoma during COVID-19 pandemic: current recommendations and considerations in Brazil by Batistella, Gabriel Novaes de Rezende, Santos, Adrialdo José, Paiva, Manoel Antonio de, Ferrigno, Robson, Camargo, Veridiana Pires de, Stavale, João Norberto, Maldaun, Marcos Vinicius Calfat

“…ABSTRACT Background: Cancer patients in general and glioblastoma patients, in particular, have an increased risk of developing complications from the severe…”
Get full text

Challenges and opportunities for sarcoma care and research in Latin America: a position paper from the LACOG sarcoma group by Pestana, Roberto Carmagnani, Lopes David, Bruna Bianca, Pires de Camargo, Veridiana, Munhoz, Rodrigo Ramella, Lopes de Mello, Celso Abdon, González Donna, María Lucila, Haro Varas, Juan Carlos, Zapata, Maycos L., Cunha Martins, Cicero Luiz, Chacon, Matias, Schmerling, Rafael, Jesus-Garcia, Reynaldo

“…As a developing region, Latin America faces unique cancer control and prevention challenges, which are intensified when considering rare cancers, including…”
Get full text

Trends in Melanoma Mortality in Brazil: A Registry-Based Study by Nader Marta, Guilherme, Munhoz, Rodrigo Ramella, Teixeira, Monica La Porte, Waldvogel, Bernadette Cunha, Pires de Camargo, Veridiana, Feher, Olavo, Sanches, Jose Antonio

“…A substantial increase in melanoma incidence has been consistently observed worldwide over the past decades. However, melanoma mortality rates have remained…”
Get full text

Non-gastrointestinal stromal tumours soft tissue sarcomas: an update by Duarte Ramos Matos, Gustavo

“…Soft tissue sarcomas (STS) encompass a diverse family of neoplasms of mesenchymal origin, marked by significant heterogeneity in terms of physiopathology,…”
Get full text

Response to Paclitaxel in an Adult Patient with Advanced Kaposiform Hemangioendothelioma by Mota, José Maurício, Scaranti, Mariana, Fonseca, Leonardo G., Tolói, Diego Araújo, de Camargo, Veridiana Pires, Munhoz, Rodrigo Ramella, Feher, Olavo, Hoff, Paulo M.

“…Background: Kaposiform hemangioendothelioma (KHE) is a rare neoplasm of vascular origin that typically arises from the skin or soft tissues as a solitary…”
Get full text

Consensus of the Brazilian Society of Infectious Diseases and Brazilian Society of Clinical Oncology on the management and treatment of Kaposi's sarcoma by Arruda, Érico, dos Anjos Jacome, Alexandre Andrade, de Castro Conde Toscano, Ana Luiza, Silvestrini, Anderson Arantes, Rêgo, André Santa Bárbara, Wiermann, Evanius Garcia, da Cunha, Geraldo Felicio, de Melo, Heloisa Ramos Lacerda, Morejón, Karen Mirna Loro, Goldani, Luciano Zubaran, Pereira, Luiz Carlos, Silva, Mariliza Henrique, Treistman, Mauro Sergio, Pereira, Mônica Cristina Toledo, Romero, Patricia Maria Bezerra Xavier, Schmerling, Rafael Aron, Guedes, Rodrigo Antonio Vieira, de Camargo, Veridiana Pires

“…Kaposi's sarcoma is a multifocal vascular lesion of low-grade potential that is most often present in mucocutaneous sites and usually also affects lymph nodes…”
Get full text

Successful Intravascular Correction of Intratumoral Pseudoaneurysm by Erosion of the Aorta in a Patient with Thoracic Giant Cell Tumor of Bone Responding to Denosumab by Munhoz, Rodrigo R., Camargo, Veridiana P., Codima, Alberto, Matutino, Adriana R. B., Kurimori, Ceci O., Toloi, Diego, Fraile, Natalia M. P., Feher, Olavo

“…Giant cell tumor of bone (GCT) is a rare, locally aggressive neoplasm characterized by the presence of giant cells with osteoclast activity. Its biology…”
Get full text

Introduction: The 2008 European Society for Medical Oncology International Symposium on Sarcomas and Gastrointestinal Stromal Tumors by Maki, Robert G., MD, PhD, de Camargo, Veridiana Pires, MD

Get full text

Other Targetable Sarcomas by Pires de Camargo, Veridiana, van de Rijn, Matt, de Alava, Enrique, Madoz-Gúrpide, Juan, Pilotti, Silvana, von Mehren, Margaret, Pedeutour, Florence, Maki, Robert G, Rutkowski, Piotr, Thomas, David M

“…Despite complex genetics, aneuploid tumors like dedifferentiated liposarcoma have specific and reproducible chromosomal changes such as amplification of HDM2…”
Get full text

Erratum on “Consensus of the Brazilian Society of Infectious Diseases and Brazilian Society of Clinical Oncology on the management and treatment of Kaposi's sarcoma” [Braz. J. Infect. Dis. 18 (3) (2014) 315–326] by Arruda, Érico, dos Anjos Jacome, Alexandre Andrade, Toscano, Ana Luiza de Castro Conde, Silvestrini, Anderson Arantes, Rêgo, André Santa Bárbara, Wiermann, Evanius Garcia, da Cunha, Geraldo Felicio, de Melo, Heloisa Ramos Lacerda, Morejón, Karen Mirna Loro, Goldani, Luciano Zubaran, Pereira, Luiz Carlos, Silva, Mariliza Henrique, Treistman, Mauro Sergio, Pereira, Mônica Cristina Toledo, Romero, Patricia Maria Bezerra Xavier, Schmerling, Rafael Aron, Guedes, Rodrigo Antonio Vieira, de Camargo, Veridiana Pires

Get full text

Treatment outcomes for adult patients with localized osteosarcoma treated with chemotherapy without methotrexate at a public hospital in Brazil by Marilia Polo Minguete-e-Silva, Renata Rodrigues da Cunha Colombo Bonadio, Gustavo Matos, Diego de Araújo Toloi, Rodrigo Ramella Munhoz, Mirella Nardo, Daniel Rebolledo, Luiz Filipe Marques Correa, Andre Mathias Baptista, Caroline Chaul de Lima Barbosa Zampieri, Olavo Feher, Veridiana Pires de Camargo

“…Introduction: Standard treatment for pediatric patients with localized osteosarcoma includes high-dose methotrexate (HDMTX), and cure rates greater than 60%…”
Get full text

Sarcoma drug approvals in Latin America compared to the FDA and EMA: An analysis by the LACOG Sarcoma Group by Carmagnani Pestana, Roberto, Dias e Silva, Douglas, David, Bruna Bianca Lopes, Schmerling, Rafael Aron, Filippi, Renee Zon, Camargo, Veridiana Pires De, Abdon Lopes de Mello, Celso, González Donna, Lucila Maria, Munhoz, Rodrigo Ramella, Haro Varas, Juan Carlos Carlos, Zapata, Maycos L., Martins, Cicero Luiz Cunha De Sousa, Chacon, Matias Rodrigo, Filho, Reynaldo Jesus Garcia

“…e13731 Background: Drug approval processes by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) often shape regulatory…”
Get full text

FDG-PET/CT response and prediction of pathological response to neoadjuvant nivolumab and ipilimumab for clinical stage III melanoma by De Barros E Silva, Milton Jose, Tavares, Monique Celeste, Lima, Joao Paulo S. N., Buzaid, Antonio C., Garcia, Daniel, Camargo, Veridiana Pires De, Molina, Andre, Bertolli, Eduardo, Lobo, Matheus, Van Akkooi, Alexander Christopher Jonathan, Pinto, Clovis, De Paula, Rafaela Brito, Lima, Eduardo, Rinck, José Augusto, Duprat, Joao

“…9585 Background: Neoadjuvant immunotherapy with nivolumab 3mg/kg and ipilimumab 1 mg/kg (N3+I1) for two cycles for clinical stage III melanoma have shown rates…”
Get full text

Proton pump inhibitors and antibiotics impact on toxicities and clinical outcomes in cancer patients treated with immunotherapy by Araujo, Haniel alves, Moniz, Camila Motta Venchiarutti, Braghiroli, Oddone Freitas Melro, Mak, Milena Perez, Uratani, Lucas Fernando, Dahmer Tiecher, Ricardo, Moraes, Priscila Muniz, Barbosa, Ingrid, Camargo, Veridiana Pires De, Braghiroli, Maria Ignez Freitas Melro, Castro, Gilberto, Hoff, Paulo Marcelo, Diz, Maria Del Pilar

“…Abstract only 2652 Background: Gut microbiome dysbiosis impairs systemic immune responses and recent evidence suggests its critical role in patients (pts)…”
Get full text